ADMA FY 2017 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23M+113.5% YoY

Gross Profit

-$6M-28.1% margin

Operating Income

-$39M-172.7% margin

Net Income

-$44M-192.3% margin

EPS (Diluted)

$-1.91

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$40M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$108M

Total Liabilities

$68M

Stockholders' Equity

$40M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$11M	+113.5%
Gross Profit	-$6M	$4M	-248.9%
Operating Income	-$39M	-$17M	-126.8%
Net Income	-$44M	-$20M	-124.2%